Medicare Enrolled

Dr. Alicia Thorne, D.O.

Endocrinology · Westerville, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
193 W SCHROCK RD, Westerville, OH 43081
6143925160
In practice since 2008 (18 years)
NPI: 1043482037 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Thorne from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Thorne? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Thorne

Dr. Alicia Thorne is an endocrinology specialist in Westerville, OH, with 18 years of NPI registration. Based on federal Medicare data, Dr. Thorne performed 1,741 Medicare services across 1,065 unique beneficiaries.

Between the years covered by Open Payments, Dr. Thorne received a total of $3,558 from 33 pharmaceutical and/or device companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Thorne is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 18% volume in OH $3,558 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,741
Medicare services
Top 18% in OH for endocrinology
1,065
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~97 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
250 $90 $170
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
197 $8 $13
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
132 $16 $35
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
112 $10 $25
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
112 $9 $22
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
105 $8 $16
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
103 $10 $23
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
99 $29 $70
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
97 $5 $28
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
79 $13 $36
Parathyroid hormone level test
A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones.
72 $40 $125
LDL cholesterol level test
A blood test that measures the amount of low-density lipoprotein (LDL) cholesterol in your blood. LDL is often referred to as "bad" cholesterol.
69 $10 $34
Urine microalbumin test (kidney screening)
A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage.
63 $6 $31
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
56 $26 $93
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
49 $8 $22
Cardiac enzyme level (CK-MB) test
A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage.
45 $6 $15
Albumin level test
A blood test that measures the amount of albumin, a protein made by the liver, in your body.
37 $5 $22
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
23 $67 $120
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
22 $49 $192
Total T3 thyroid hormone test
A blood test that measures the total amount of triiodothyronine (T3) hormone in your body. T3 is a thyroid hormone that helps regulate metabolism and energy levels.
19 $14 $67
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,558
Total received (2018-2024)
Avg $508/year across 7 years
Top 37% in OH for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
250
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,558 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$247
2023
$929
2022
$346
2021
$163
2020
$303
2019
$693
2018
$878

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$50
Abbott Laboratories
$41
Lilly USA, LLC
$41
Corcept Therapeutics
$23
Antares Pharma, Inc.
$23
Dexcom, Inc.
$21
Novo Nordisk Inc
$16
Novartis Pharmaceuticals Corporation
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 53.8% of 2024 payments
All-time payments by company (2018-2024) ›
MannKind Corporation
$608
Lilly USA, LLC
$399
Novo Nordisk Inc
$380
Mannkind Corporation
$370
Dexcom, Inc.
$323
Abbott Laboratories
$232
Corcept Therapeutics
$131
Amgen Inc.
$100
AstraZeneca Pharmaceuticals LP
$100
SANOFI-AVENTIS U.S. LLC
$96
Amarin Pharma Inc.
$95
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$74
Tandem Diabetes Care, Inc.
$70
Insulet Corporation
$68
Radius Health, Inc.
$41
Regeneron Healthcare Solutions, Inc.
$40
Medtronic, Inc.
$38
AbbVie, Inc.
$37
AbbVie Inc.
$32
Bayer Healthcare Pharmaceuticals Inc.
$31
Merck Sharp & Dohme Corporation
$25
Antares Pharma, Inc.
$23
DEXCOM, INC.
$20
Janssen Pharmaceuticals, Inc
$20
IBSA Pharma Inc.
$20
Shire North American Group Inc
$20
Amryt Pharma Holdings Ltd
$17
Novartis Pharmaceuticals Corporation
$16
PFIZER INC.
$15
OPKO Pharmaceuticals, LLC
$14
Nevro Corp.
$13
Lupin Inc.
$11
Top 3 companies account for 39.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · CYCLOSET · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · HUMULIN · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · MOUNJARO · MYCAPSSA · NATPARA (PARATHYROID HORMONE) · Omnia · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · Rayaldee · Repatha · Rybelsus · SOLIQUA 100/33 · SOLOSEC · SOMAVERT · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TOUJEO · TRULICITY · Tymlos · Vascepa · Wegovy · XARELTO · XYOSTED · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Westerville?
Compare endocrinologists in the Westerville area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
66
Per 100K population
5.0
County median income
$73,795
Nearest hospital
MOUNT CARMEL ST ANN'S
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Thorne is a clinical cardiology specialist, with above-average Medicare volume (top 18% in OH), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Thorne experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Thorne performed 250 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Thorne receive payments from pharmaceutical companies?
Yes. Dr. Thorne received a total of $3,558 from 33 companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Thorne's costs compare to other endocrinologists in Westerville?
Dr. Thorne's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Thorne) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →